Animal Models Core

动物模型核心

基本信息

  • 批准号:
    10470334
  • 负责人:
  • 金额:
    $ 59.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-09-01 至 2025-07-31
  • 项目状态:
    未结题

项目摘要

CORE C – ANIMAL MODELS PROJECT SUMMARY Cystic fibrosis (CF) is a common autosomal recessive disease caused by mutations in the gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR). CF affects multiple organs, including lungs, pancreas, intestine, liver, sweat glands, gallbladder, and the male genital tract. Airway infection and inflammation currently cause most of the morbidity and mortality. Although several therapies have improved the lives of patients, current treatments are inadequate and CF remains a lethal disease. Our knowledge about the pathogenesis of the disease, its progression, and the state of the neonatal lung is inadequate. These gaps in our knowledge have hindered attempts to develop better treatments and preventions for CF lung disease. A major impediment to addressing these issues had been limitations of animal models. Although mouse strains carrying null and missense CFTR mutations have made enormous contributions, CF mice do not develop the airway or pancreatic disease typically found in humans. We have generated CF ferrets and pigs that replicate many of the key features of human CF disease including intestinal obstruction, exocrine pancreatic destruction, micro-gallbladder, vas deferens abnormalities, focal biliary cirrhosis, congenital airway structural abnormalities, and airway and sinus infection with time. The goals of the Animal Models Core will be: (1) To provide Program investigators with non-CF and CF ferrets and pigs so that they can successfully complete their project aims. (2) To build new genetically engineered CF ferret models that express CFTR in a regulated fashion. (3) To assist projects in carrying out small molecule delivery, the harvesting of biologic samples from live animals (e.g., bronchoalveolar lavage fluid, blood, and microbiological samples), and the care and analysis of study animals. (4) To assist projects in record keeping and coordinate animal usage among projects. The Animal Models Core will function seamlessly through already established interactions with the Project Leaders, Pathology Core, In Vitro Models and Cell Culture Core, and the Administrative Core. The success of the Animal Models Core is ensured because of the commitment, experience, and expertise that the personnel bring to the Core.
核心C -动物模型 项目摘要 囊性纤维化(CF)是一种常见的常染色体隐性遗传病,由编码 囊性纤维化跨膜传导调节因子(CFTR)。CF影响多个器官,包括肺, 胰腺、肠、肝、汗腺、胆囊和男性生殖道。呼吸道感染和 炎症目前引起大部分的发病率和死亡率。虽然有几种疗法已经改善了 然而,由于患者的生命受到威胁,目前的治疗是不充分的,CF仍然是一种致命的疾病。我们的知识 该疾病的发病机制,其进展和新生儿肺的状态是不够的。这些差距在 我们的知识阻碍了开发CF肺病的更好治疗和预防的尝试。一 解决这些问题的主要障碍是动物模型的局限性。虽然小鼠品系 携带无效和错义CFTR突变的小鼠做出了巨大的贡献,CF小鼠不会发展出 呼吸道或胰腺疾病,通常见于人类。我们已经培育出CF雪貂和猪, 人CF疾病的许多关键特征包括肠梗阻,胰腺外分泌破坏, 微胆囊,输精管异常,局灶性胆汁性肝硬化,先天性气道结构异常, 以及气道和鼻窦感染。动物模型中心的目标是:(1)提供项目 研究人员与非CF和CF雪貂和猪,使他们能够成功地完成他们的项目目标。(二) 建立新的基因工程CF雪貂模型,以调控的方式表达CFTR。(3)协助 在进行小分子递送,从活动物中收获生物样品(例如, 支气管肺泡灌洗液、血液和微生物样品),以及研究动物的护理和分析。 (4)协助项目做好记录,协调项目间动物的使用。动物模型核心 将通过与项目负责人、病理学核心、体外 模型和细胞培养核心,以及管理核心。确保动物模型核心的成功 这是因为这些人给核心带来的承诺、经验和专业知识。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAVID A STOLTZ其他文献

FATAL LUNG INJURY SECONDARY TO TRIMETHOPRIM-SULFAMETHOXAZOLE
  • DOI:
    10.1016/j.chest.2023.07.1615
  • 发表时间:
    2023-10-01
  • 期刊:
  • 影响因子:
  • 作者:
    HALEY PYSICK;DAVID A STOLTZ
  • 通讯作者:
    DAVID A STOLTZ

DAVID A STOLTZ的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAVID A STOLTZ', 18)}}的其他基金

Climate Change and Lung Health Training Program
气候变化与肺部健康培训计划
  • 批准号:
    10556149
  • 财政年份:
    2023
  • 资助金额:
    $ 59.97万
  • 项目类别:
Testing the Contributions of Airway Submucosal Glands and Surface Epithelia to Lung Health
测试气道粘膜下腺和表面上皮对肺部健康的贡献
  • 批准号:
    10597111
  • 财政年份:
    2022
  • 资助金额:
    $ 59.97万
  • 项目类别:
Animal Models Core
动物模型核心
  • 批准号:
    10677590
  • 财政年份:
    2020
  • 资助金额:
    $ 59.97万
  • 项目类别:
Animal Models Core
动物模型核心
  • 批准号:
    10024664
  • 财政年份:
    2020
  • 资助金额:
    $ 59.97万
  • 项目类别:
Animal Models Core
动物模型核心
  • 批准号:
    10248526
  • 财政年份:
    2020
  • 资助金额:
    $ 59.97万
  • 项目类别:
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis
气道碱化和重新利用氨丁三醇作为囊性纤维化的治疗方法
  • 批准号:
    10155587
  • 财政年份:
    2017
  • 资助金额:
    $ 59.97万
  • 项目类别:
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis
气道碱化和重新利用氨丁三醇作为囊性纤维化的治疗方法
  • 批准号:
    9289053
  • 财政年份:
    2017
  • 资助金额:
    $ 59.97万
  • 项目类别:
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis
气道碱化和重新利用氨丁三醇作为囊性纤维化的治疗方法
  • 批准号:
    9918957
  • 财政年份:
    2017
  • 资助金额:
    $ 59.97万
  • 项目类别:
Airway Goblet Cells: Friend or Foe?
气道杯状细胞:朋友还是敌人?
  • 批准号:
    8355114
  • 财政年份:
    2012
  • 资助金额:
    $ 59.97万
  • 项目类别:
Paraoxonase-2 S311C Polymorphism Alters Glycosylation and Lactonase Activity
Paraoxonase-2 S311C 多态性改变糖基化和内酯酶活性
  • 批准号:
    8110743
  • 财政年份:
    2010
  • 资助金额:
    $ 59.97万
  • 项目类别:

相似海外基金

RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
  • 批准号:
    2327346
  • 财政年份:
    2024
  • 资助金额:
    $ 59.97万
  • 项目类别:
    Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
  • 批准号:
    2312555
  • 财政年份:
    2024
  • 资助金额:
    $ 59.97万
  • 项目类别:
    Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
  • 批准号:
    BB/Z514391/1
  • 财政年份:
    2024
  • 资助金额:
    $ 59.97万
  • 项目类别:
    Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
  • 批准号:
    ES/Z502595/1
  • 财政年份:
    2024
  • 资助金额:
    $ 59.97万
  • 项目类别:
    Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
  • 批准号:
    ES/Z000149/1
  • 财政年份:
    2024
  • 资助金额:
    $ 59.97万
  • 项目类别:
    Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
  • 批准号:
    23K24936
  • 财政年份:
    2024
  • 资助金额:
    $ 59.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
  • 批准号:
    2901648
  • 财政年份:
    2024
  • 资助金额:
    $ 59.97万
  • 项目类别:
    Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
  • 批准号:
    2301846
  • 财政年份:
    2023
  • 资助金额:
    $ 59.97万
  • 项目类别:
    Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
  • 批准号:
    488039
  • 财政年份:
    2023
  • 资助金额:
    $ 59.97万
  • 项目类别:
    Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
  • 批准号:
    23K16076
  • 财政年份:
    2023
  • 资助金额:
    $ 59.97万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了